Atlas Trials

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Clinical trial NCT05188742 · UNKNOWN

Trial details

NCT number
NCT05188742
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive Bladder Syndrome
Start date
2021-11-10
Primary completion
2023-09-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.